Literature DB >> 1871715

A photometric assay for blood coagulation factor XIII.

K Fickenscher1, A Aab, W Stüber.   

Abstract

An assay for a direct photometric determination of F XIII in untreated and undiluted plasma was developed. In a one-step procedure F XIII is activated by thrombin and Ca2+ and cross-links glycine-ethylester to a specific glutamine containing peptide substrate. The released ammonia is incorporated into alpha-ketoglutarate by glutamate dehydrogenase, and the NADH consumption of this reaction is measured photometrically at 340 nm. NADH-consumption is directly proportional to the F XIII activity. Fibrin polymerization and the corresponding turbidity is avoided by the use of a fibrin aggregation inhibitor. The procedure is rapid and simple and enables to measure within the range of 0 to 150% F XIII. It can be performed with automated analyzers as well as with common photometric equipment. The normal range of F XIII activity in 167 healthy donors was determined to be 70 to 140%.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871715

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  25 in total

1.  Effect of factor XIII on endothelial barrier function.

Authors:  T Noll; G Wozniak; K McCarson; A Hajimohammad; H J Metzner; J Inserte; W Kummer; F W Hehrlein; H M Piper
Journal:  J Exp Med       Date:  1999-05-03       Impact factor: 14.307

2.  The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore.

Authors:  Chew-Kiat Heng; Suman Lal; Nilmani Saha; Poh-Sim Low; M Ilyas Kamboh
Journal:  Hum Genet       Date:  2003-10-31       Impact factor: 4.132

3.  Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function.

Authors:  Vytautas Ivaskevicius; Arijit Biswas; Carville Bevans; Verena Schroeder; Hans Peter Kohler; Hannelore Rott; Susan Halimeh; Petro E Petrides; Harald Lenk; Manuele Krause; Bruno Miterski; Ursula Harbrecht; Johannes Oldenburg
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

4.  Case report of an acquired factor XIII inhibitor: diagnosis and management.

Authors:  Thomas F Gregory; Barry Cooper
Journal:  Proc (Bayl Univ Med Cent)       Date:  2006-07

Review 5.  Newly-Recognized Roles of Factor XIII in Thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

6.  Evaluating factor XIII specificity for glutamine-containing substrates using a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry assay.

Authors:  Prakash G Doiphode; Marina V Malovichko; Kelly Njine Mouapi; Muriel C Maurer
Journal:  Anal Biochem       Date:  2014-04-19       Impact factor: 3.365

7.  Activation of factor XIII is accompanied by a change in oligomerization state.

Authors:  Boris A Anokhin; Vilius Stribinskis; William L Dean; Muriel C Maurer
Journal:  FEBS J       Date:  2017-10-03       Impact factor: 5.542

8.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

9.  Age-related effects of regular physical activity on hemostatic factors in men.

Authors:  Jun Sugawara; Koichiro Hayashi; Sumiko Kurachi; Taku Tanaka; Takashi Yokoi; Kotoku Kurachi
Journal:  J Thromb Thrombolysis       Date:  2007-09-10       Impact factor: 2.300

10.  Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Authors:  Siiri E Iismaa; Sara Holman; Merridee A Wouters; Laszlo Lorand; Robert M Graham; Ahsan Husain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.